Close Menu

NanoInk

NEW YORK (GenomeWeb News) – NanoInk today announced a non-exclusive deal with Genetimes Technology for the distribution of NanoInk's products in China.

NEW YORK (GenomeWeb News) – NanoInk today announced E-Hong Instruments will distribute its desktop nanofabrication equipment in Taiwan.
The deal, the financial terms of which were not disclosed, includes the NLP 2000 System, the DPN 5000 System, and Mems-fabricated consumables.

NEW YORK (GenomeWeb News) – The Research Institute of Biomolecule Metrology will distribute NanoInk desktop nanofabrication equipment in Japan, NanoInk's NanoFabrication Systems Division announced today.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – NanoInk today announced an agreement to license five new technologies from Northwestern University.

NanoInk this week released its new NanoArray Assay System for the automated analysis of its protein NanoArray assays.

NanoInk this week launched its NanoArray Assay System for the automated analysis of its protein NanoArray assays.

Cambridge Bioscience will be NanoInk's exclusive distributor in the UK and Ireland, NanoInk said this week.

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – NanoInk today announced that Cambridge Bioscience will exclusively distribute its desktop nanofabrication equipment in the UK and Ireland.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – NanoInk today announced an agreement with NanoGulf as its exclusive distributor in parts of the Middle East.

Pages

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.